Pathological grade | Case | Lesion | Location | Unenhanced CT | Contrast-enhanced series (attenuation) | Type of dynamic enhanced curvesb
|
---|
| | Single | Multiple | Right | Left | Hypo | Hyper | Homogeneity | Arterial phasea
| Portal phasea
| Delayed phasea
| Type II | Type III |
---|
| | | | | | | | Yes | No | Markedly hyper | Moderately hyper | Hyper | Iso | Hyper | Iso |
---|
G1 | 8 | 8 | 0 | 7 | 1 | 7 | 1 | 6 | 2 | 7 | 1 | 8 | 0 | 8 | 0 | 1 | 7 |
G2 | 10 | 7 | 3 | 6 | 1 | 10 | 0 | 4 | 6 | 8 | 2 | 8 | 2 | 9 | 1 | 1 | 9 |
G3 | 11 | 4 | 7 | 2 | 2 | 10 | 1 | 0 | 11 | 9 | 2 | 11 | 0 | 9 | 2 | 1 | 11 |
-
aIf the tumor showed a cystic or predominantly cystic appearance, the attenuation of contrast-enhanced series on arterial phase, portal phase and delayed phase were measured in the margin region. The type of dynamic enhanced curves were obtained from the margin or solid content
-
bType I dynamic enhancement curves show lesions with gradual enhancements and peak enhancements in the delayed phase. Type II dynamic enhancement curves show lesions with peak enhancements at the arterial phase and no decrease at the portal phase or delayed phase. Type III curves shows lesions with peak enhancements at the arterial phase and a slight decrease at the portal phase and the delayed phase